Sunitinib therapy for patients (pts) with metastatic renal cell carcinoma (mRCC): Updated results of two phase II trials and prognostic factor analysis for survival
暂无分享,去创建一个
R. Motzer | M. Michaelson | B. Redman | G. Wilding | J. Rosenberg | C. Baum | R. Bukowski | G. Hudes | D. George | S. Kim